Acessibilidade / Reportar erro

Radiation recall dermatitis induced by ibuprofen Study conducted at the Chengdu Second People’s Hospital, Chengdu, Sichuan, China.

Dear Editor,

A 31-year-old female presented with a 1-week history of burning, painful and pruritic skin eruptions affecting the left chest and axillary region. She had previously undergone a modified radical mastectomy and lymph node dissection for ductal breast carcinoma 1 year ago. Then, the patient has prescribed 24 weeks of chemotherapy with doxorubicin, cyclophosphamide, and paclitaxel. Two months ago, she was treated with 3-dimensional conformal radiation therapy (50 Gy: 25 fractions for five weeks). Mild erythema and scales with pruritus were observed at the end of radiotherapy and subsided with 0.05% desonide cream within several days. Six days before the eruptions appeared, she had taken ibuprofen orally for arthralgia. The inflammatory eruptions involved the areas previously treated with radiation and initially manifested well-demarcated rectangular erythema, edema, and tiny papules, followed by blisters and erosions (Fig. 1). The dermoscopy showed multiple brown circles along with the hair follicles as well as scales (Fig. 2). The histopathology revealed intraepidermal vesiculation, papillary dermal edema, and perivascular inflammatory infiltrate in the upper dermis (Fig. 3).

Figure 1
Well-demarcated rectangular erythema with edema, tiny papules, and erosions affecting the left chest and axillary region.

Figure 2
The dermoscopy showed multiple brown circles along with the hair follicles as well as white scales.

Figure 3
The histopathology revealed intraepidermal vesiculation, papillary dermal edema, and perivascular inflammatory infiltrate in the upper dermis (Hematoxylin & eosin, × 100).

A diagnosis of radiation recall dermatitis (RRD) induced by ibuprofen was made. The patient was relieved after 1 week of treatment with oral loratadine and topical 0.05% halometasone cream.

RRD is an uncommon acute dermatitis at regions of the previous radiotherapy in response to drug administration. The most commonly implicated medications are anticancer drugs, in particular cytotoxics, but other drugs can also induce RRD, including antibiotics, antituberculosis drugs, nimesulide, phentermine, and simvastatin.11 Burris HA, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15:1227–37. Chu et al. reported only one case of RRD following topical agents.22 Chu CH, Cheng YP, Liang CW, Chiu HC, Jee SH, Chan JYL, et al. Radiation recall dermatitis induced by topical tacrolimus for post-irradiation morphea. J Eur Acad Dermatol Venereol. 2017;31:e80–1. RRD can occur at any time between days to years after radiation exposure. The time to develop the reaction may be longer for oral than intravenously administered drugs.33 Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59:237–45. RRD is drug-specific for any individual; it is impossible to predict which individuals will react to which drugs, and rechallenge does not uniformly cause a reaction.11 Burris HA, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15:1227–37. Several possible explanations for the pathogenesis of RRD have been proposed including memory reaction of surviving epithelial stem cells, radiation-induced mutation, post-radiation vascular damage, and hypersensitivity reaction.33 Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59:237–45.

Most of the time, RRD presents as erythema, papules, edema, vesicles, desquamation, or even ulceration.44 Guarneri C, Guarneri B. Radiation recall dermatitis. CMAJ. 2010;182:E150. The area affected by RRD corresponds to the site previously irradiated, although may occasionally become generalized. The histological appearance is nonspecific and sometimes overlaps with acute radiation dermatitis. It is important to note however, radiation recall reactions may involve deep tissues and organs.11 Burris HA, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15:1227–37.

To our knowledge, there have been no reports of RRD induced by ibuprofen. This is the second case of RRD following a non-steroidal anti-inflammatory drug, and the first was induced by nimesulide.55 Ng AWY, Wong FCS, Tung SY, S K O. Nimesulide – a new trigger of radiation recall reaction. Clin Oncol (R Coll Radiol). 2007;19:364–5. The dermoscopic manifestation shows a brown circle around the hair follicle that is similar to the dermoscopic appearance of lichen pilaris.

  • Study conducted at the Chengdu Second People’s Hospital, Chengdu, Sichuan, China.
  • Financial support
    None declared.

References

  • 1
    Burris HA, Hurtig J. Radiation recall with anticancer agents. Oncologist. 2010;15:1227–37.
  • 2
    Chu CH, Cheng YP, Liang CW, Chiu HC, Jee SH, Chan JYL, et al. Radiation recall dermatitis induced by topical tacrolimus for post-irradiation morphea. J Eur Acad Dermatol Venereol. 2017;31:e80–1.
  • 3
    Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol. 2001;59:237–45.
  • 4
    Guarneri C, Guarneri B. Radiation recall dermatitis. CMAJ. 2010;182:E150.
  • 5
    Ng AWY, Wong FCS, Tung SY, S K O. Nimesulide – a new trigger of radiation recall reaction. Clin Oncol (R Coll Radiol). 2007;19:364–5.

Publication Dates

  • Publication in this collection
    04 Aug 2023
  • Date of issue
    2023

History

  • Received
    29 July 2021
  • Accepted
    22 Aug 2021
  • Published
    24 Mar 2023
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br